Evommune, Inc. (NYSE: EVMN) (the "Company"), a clinical-stage biotechnology company developing innovative therapies that ...

Biphenomycins, natural products derived from bacteria, show excellent antimicrobial activity, but have long remained out of reach for drug development. The main obstacle was the limited understanding ...

U. labor costs increased slightly less than expected in the third quarter as a softening labor market curbed wage growth, ...

The American Federation for Aging Research (AFAR) and Hevolution Foundation are pleased to announce the third cohort of theHevolution/AFAR New ...